Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.47% is in line with its 5-year average of 4.56%, around the middle of its 5-year range (3.31%–5.71%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.74% below its 12-month average of 4.84%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
4.47%
RETURN ON ASSETS (ROA) AVG TTM
4.84%
RETURN ON ASSETS (ROA) AVG 3Y
4.27%
RETURN ON ASSETS (ROA) AVG 5Y
4.56%
RETURN ON ASSETS (ROA) AVG 10Y
3.86%
RETURN ON ASSETS (ROA) AVG 15Y
4.41%
RETURN ON ASSETS (ROA) AVG 20Y
4.37%
CURRENT VS TTM AVG
-7.74%
CURRENT VS 3Y AVG
+4.62%
CURRENT VS 5Y AVG
-1.94%
CURRENT VS 10Y AVG
+15.67%
CURRENT VS 15Y AVG
+1.48%
CURRENT VS 20Y AVG
+2.22%
SECTOR MEDIAN · HEALTHCARE
4.97%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-10.06%
vs the sector median at left
Market Cap
$14.80B
Return on Assets (ROA)
10.16%
TTM Avg
7.10%
3Y Avg
8.43%
5Y Avg
7.35%
Market Cap
$16.11B
Return on Assets (ROA)
23.89%
TTM Avg
21.05%
3Y Avg
19.32%
5Y Avg
16.45%
Market Cap
$14.10B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$16.97B
Return on Assets (ROA)
5.92%
TTM Avg
7.45%
3Y Avg
8.56%
5Y Avg
11.79%
Market Cap
$13.51B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$18.17B
Return on Assets (ROA)
3.35%
TTM Avg
3.64%
3Y Avg
3.29%
5Y Avg
2.38%
Market Cap
$12.55B
Return on Assets (ROA)
2.01%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$12.11B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DaVita Inc. (DVA) | $15.41B | 4.47% | 4.84% | 4.27% | 4.56% |
| Solventum Corporation (SOLV)vs › | $14.80B | 10.16% | 7.10% | 8.43% | 7.35% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.11B | 23.89% | 21.05% | 19.32% | 16.45% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 1.89% | 3.10% | 3.02% | 7.71% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
| Baxter International Inc. (BAX)vs › | $13.51B | -5.37% | -3.64% | -1.62% | 0.47% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.17B | 3.35% | 3.64% | 3.29% | 2.38% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 2.01% | 2.19% | 1.89% | 3.83% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 6.44% | 6.68% | 6.69% | 12.75% |
| Insulet Corp. (PODD)vs › | $11.45B | 10.14% | 10.65% | 7.37% | 5.11% |
ROA
4.5%
ROE
-114.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.27% |
| 2024-12-31 | 5.42% |
| 2023-12-31 | 4.09% |
| 2022-12-31 | 3.31% |
| 2021-12-31 | 5.71% |
| 2020-12-31 | 4.55% |
| 2019-12-31 | 4.68% |
| 2018-12-31 | 0.83% |
| 2017-12-31 | 3.50% |
| 2016-12-31 | 4.69% |
| 2015-12-31 | 1.46% |
| 2014-12-31 | 4.03% |
| 2013-12-31 | 3.70% |
| 2012-12-31 | 3.34% |
| 2011-12-31 | 5.38% |
| 2010-12-31 | 5.00% |
| 2009-12-31 | 5.59% |
| 2008-12-31 | 5.14% |
| 2007-12-31 | 5.50% |
| 2006-12-31 | 4.46% |
| 2005-12-31 | 3.64% |
| 2004-12-31 | 8.85% |
| 2003-12-31 | 9.04% |
| 2002-12-31 | 8.86% |
| 2001-12-31 | 8.26% |
| 2000-12-31 | 0.84% |
| 1999-12-31 | -7.16% |
| 1998-12-31 | -0.49% |
| 1997-12-31 | 6.54% |
| 1996-12-31 | 7.14% |
